These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 15063084)

  • 21. Anti-TNFalpha therapy of rheumatoid arthritis: what can we learn about chronic disease?
    Feldmann M; Brennan FM; Paleolog E; Cope A; Taylor P; Williams R; Woody J; Maini RN
    Novartis Found Symp; 2004; 256():53-69; discussion 69-73, 106-11, 266-9. PubMed ID: 15027483
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytokine expression and networks in rheumatoid arthritis: rationale for anti-TNF alpha antibody therapy and its mechanism of action.
    Feldmann M; Brennan FM; Williams RO; Elliott MJ; Maini RN
    J Inflamm; 1995-1996; 47(1-2):90-6. PubMed ID: 8913935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The macrophage, TNF, and other cytokines.
    Pass HI; Mew D; Pass HA; Temeck BK
    Chest Surg Clin N Am; 1995 Feb; 5(1):73-90. PubMed ID: 7538021
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunotherapy.
    James G
    Rev Invest Clin; 1990 Jul; 42 Suppl():22-7. PubMed ID: 19256128
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-TNF-alpha and Th1 cytokine-directed therapies for the treatment of asthma.
    Cazzola M; Polosa R
    Curr Opin Allergy Clin Immunol; 2006 Feb; 6(1):43-50. PubMed ID: 16505611
    [TBL] [Abstract][Full Text] [Related]  

  • 26. What have we learnt from targeted anti-TNF therapy?
    Feldmann M; Williams RO; Paleolog E
    Ann Rheum Dis; 2010 Jan; 69 Suppl 1():i97-99. PubMed ID: 19995756
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biological agents in rheumatoid arthritis.
    Shankar S; Handa R
    J Postgrad Med; 2004; 50(4):293-9. PubMed ID: 15623977
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rheumatoid arthritis: guidelines for emerging therapies.
    Blumberg SN; Fox DA
    Am J Manag Care; 2001 Jun; 7(6):617-26. PubMed ID: 11439735
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Anti-cytokine therapy in inflammatory joint diseases].
    Ehrenfeld M; Langevitz P; Shoenfeld Y
    Harefuah; 1999 Aug; 137(3-4):120-4. PubMed ID: 10959300
    [No Abstract]   [Full Text] [Related]  

  • 30. [Cytokines and anti-cytokines in inflammatory rheumatism].
    Dayer JM
    Rev Rhum Ed Fr; 1994 Dec; 61(10 Pt 2):173S-180S. PubMed ID: 7858569
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytokines and immunological monitoring.
    Kopp WC; Holmlund JT
    Cancer Chemother Biol Response Modif; 1996; 16():189-238. PubMed ID: 8639383
    [No Abstract]   [Full Text] [Related]  

  • 32. Future trends in the treatment of rheumatoid arthritis: cytokine targets.
    Breedveld FC
    Rheumatology (Oxford); 1999 Nov; 38 Suppl 2():11-3. PubMed ID: 10646483
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TNF inhibitors - new and old agents for rheumatoid arthritis.
    Simsek I
    Bull NYU Hosp Jt Dis; 2010; 68(3):204-10. PubMed ID: 20969553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The first decade of biologic TNF antagonists in clinical practice: lessons learned, unresolved issues and future directions.
    Sfikakis PP
    Curr Dir Autoimmun; 2010; 11():180-210. PubMed ID: 20173395
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lasker Clinical Medical Research Award. TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases.
    Feldmann M; Maini RN
    Nat Med; 2003 Oct; 9(10):1245-50. PubMed ID: 14520364
    [No Abstract]   [Full Text] [Related]  

  • 36. The role of tumor necrosis factor in health and disease.
    Beutler BA
    J Rheumatol Suppl; 1999 May; 57():16-21. PubMed ID: 10328138
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coming of age: anti-cytokine therapies.
    Song XY; Torphy TJ; Griswold DE; Shealy D
    Mol Interv; 2002 Feb; 2(1):36-46. PubMed ID: 14993360
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The mode of action of cytokine inhibitors.
    Arend WP
    J Rheumatol Suppl; 2002 Sep; 65():16-21. PubMed ID: 12236617
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytokines as therapeutic drugs.
    Schooltink H; Rose-John S
    J Interferon Cytokine Res; 2002 May; 22(5):505-16. PubMed ID: 12060489
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anticytokine therapy--new approach to the treatment of autoimmune and cytokine-disturbance diseases.
    Skurkovich SV; Skurkovich B; Kelly JA
    Med Hypotheses; 2002 Dec; 59(6):770-80. PubMed ID: 12445524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.